Allianz Asset Management Gmb H Astrazeneca PLC Transaction History

Allianz Asset Management Gmb H

$74.9 Billion
Q2 2025

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $209,539 - $239,465	2,733 Added 43.69%	8,988 $700,000
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $196,688 - $237,963	2,944 Added 88.92%	6,255 $487,000
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $202,070 - $230,346	3,311 New	3,311 $224,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $159,113 - $191,010	-2,685 Reduced 0.16%	1,699,687 $112 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $24.9 Million - $30 Million	447,035 Added 35.61%	1,702,372 $113 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $822,616 - $972,003	-15,228 Reduced 1.2%	1,255,337 $73.1 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $15.1 Million - $16.5 Million	271,583 Added 27.19%	1,270,565 $76.3 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $26.4 Million - $32.8 Million	-544,874 Reduced 35.29%	998,982 $59.8 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $1.1 Million - $1.27 Million	-23,260 Reduced 1.48%	1,543,856 $76.8 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $801,501 - $958,432	-16,519 Reduced 1.04%	1,567,116 $78.3 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $441,913 - $508,779	8,327 Added 0.53%	1,583,635 $86.8 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $113,827 - $146,073	-2,641 Reduced 0.17%	1,575,308 $83.3 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $7.01 Million - $9.52 Million	-185,527 Reduced 10.52%	1,577,949 $70.5 Million
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $3.9 Million - $4.63 Million	-91,755 Reduced 4.95%	1,763,476 $87.9 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $54 Million - $61.2 Million	1,345,626 Added 264.05%	1,855,231 $82.7 Million
Q2 2019 Aug 08, 2019	BUY	$37.28 - $41.68 $2.06 Million - $2.3 Million	55,273 Added 12.17%	509,605 $21 Million
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $5.27 Million - $6.38 Million	148,410 Added 48.51%	454,332 $18.4 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $3,612 - $4,066	-98 Reduced 0.03%	305,922 $11.6 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $7.42 Million - $8.48 Million	213,605 Added 231.14%	306,020 $12.1 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $20,730 - $22,230	600 Added 0.65%	92,415 $3.25 Million
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $151,002 - $167,765	-4,580 Reduced 4.75%	91,815 $3.21 Million
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $587,150 - $636,369	18,297 Added 23.43%	96,395 $3.35 Million
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $1.35 Million - $1.58 Million	-46,525 Reduced 37.33%	78,098 $2.65 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-103,231 Reduced 45.31%	124,623 $4.25 Million
Q1 2017 Apr 17, 2019	SELL	N/A	-70,154 Reduced 23.54%	227,854 $7.1 Million
Q4 2016 Apr 17, 2019	BUY	N/A	120,774 Added 68.14%	298,008 $8.14 Million
Q3 2016 Apr 17, 2019	BUY	N/A	177,234	177,234 $5.86 Million

Others Institutions Holding AZN

# of Institutions

1,425

Shares Held

505M

Call Options Held

9.82M

Put Options Held

3.14M

Price T Rowe Associates Inc Baltimore, MD

57.1M
Shares

$4.22 Billion
0.52% of portfolio
Primecap Management CO Pasadena, CA

40.7M
Shares

$3.01 Billion
2.53% of portfolio
Wellington Management Group LLP Boston, MA

35.6M
Shares

$2.64 Billion
0.52% of portfolio
Bank Of America Corp Charlotte, NC

31.8M
Shares

$2.36 Billion
0.19% of portfolio
Capital International Investors Los Angeles, CA

31.3M
Shares

$2.31 Billion
0.47% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $229B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account